No Data
No Data
Express News | Enveric Biosciences Inc: Qtrly Loss per Share $4.83
Enveric Biosciences | 8-K: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024 Product Development Highlights:
Express News | Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024
Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024
Enveric Biosciences | 10-K: Annual report
Express News | Enveric Biosciences Canada Inc. Awarded US Patent US 20250100967 A1 Titled "HYDROXYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING"